News + Filings Holdings
|
Altium Capital Management LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
BELLUS Health Inc.
| BLU | Common | 0 | -1,132,000 | 0 | -8,150,400,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Arcellx, Inc.
| ACLX | Common | 0 | -150,000 | 0 | -4,621,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
AVADEL PHARMACEUTICALS PLC
| AVDL | SPONSORED ADR | 0 | -500,000 | 0 | -4,580,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
GLAUKOS Corp
| GKOS | Common | 0 | -91,000 | 0 | -4,559,100,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Penumbra Inc
| PEN | Common | 0 | -16,000 | 0 | -4,459,040,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Alphatec Holdings, Inc.
| ATEC | COM NEW | 0 | -270,000 | 0 | -4,212,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
MYRIAD GENETICS INC
| MYGN | Common | 0 | -180,000 | 0 | -4,181,400,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
NEOGENOMICS INC
| NEO | COMMON | 0 | -240,000 | 0 | -4,178,400,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Akoya Biosciences, Inc.
| AKYA | Common | 0 | -500,000 | 0 | -4,090,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
RESMED INC
| RMD | Common | 0 | -17,000 | 0 | -3,722,830,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
CTI BIOPHARMA CORP
| CTIC | Common | 0 | -850,000 | 0 | -3,570,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Biohaven Pharmaceutical Holding Co Ltd.
| BHVN | COM | 0 | -260,000 | 0 | -3,551,600,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
IVERIC bio, Inc.
| ISEE | COM | 0 | -130,000 | 0 | -3,162,900,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Varex Imaging Corp
| VREX | COMMON STOCK | 0 | -165,000 | 0 | -3,001,350,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Inspire Medical Systems, Inc.
| INSP | Common | 0 | -12,500 | 0 | -2,925,875,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
KORU Medical Systems, Inc.
| REPR | Common | 0 | -685,002 | 0 | -2,890,708,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
BridgeBio Pharma, Inc.
| BBIO | Common | 0 | -155,000 | 0 | -2,569,900,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
MIMEDX GROUP, INC.
| MDXG | Common | 0 | -748,000 | 0 | -2,550,680,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
NanoString Technologies Inc
| NSTG | Common | 0 | -225,992 | 0 | -2,237,321,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
ILLUMINA, INC.
| ILMN | Common | 0 | -9,000 | 0 | -2,092,950,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
TG Venture Acquisition Corp.
| | Common | 0 | -200,000 | 0 | -2,070,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
| PACB | Common | 0 | -178,000 | 0 | -2,061,240,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
BioLineRx Ltd.
| BLRX | SPONSORED ADS | 0 | -2,279,657 | 0 | -2,020,916,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
CVRx, Inc.
| CVRX | COM | 0 | -205,000 | 0 | -1,910,600,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Ventyx Biosciences, Inc.
| VTYX | Common | 0 | -55,000 | 0 | -1,842,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Silk Road Medical Inc
| SILK | COMMON STOCK | 0 | -45,000 | 0 | -1,760,850,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
GeneDx Holdings Corp.
| SMFR | Common | 0 | -4,588,000 | 0 | -1,674,620,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Vaxcyte, Inc.
| PCVX | Common | 0 | -43,000 | 0 | -1,611,640,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
MARINUS PHARMACEUTICALS, INC.
| MRNS | Common | 0 | -228,714 | 0 | -1,578,127,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Ault Disruptive Technologies Corp
| ADRT | Common | 0 | -150,000 | 0 | -1,570,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Theseus Pharmaceuticals, Inc.
| THRX | Common | 0 | -112,614 | 0 | -1,000,012,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Coliseum Acquisition Corp.
| MITA | COMM | 0 | -85,000 | 0 | -872,100,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Invitae Corp
| NVTA | COM | 0 | -409,200 | 0 | -552,420,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
GSR II Meteora Acquisition Corp.
| GSRM | Common | 0 | -50,000 | 0 | -517,500,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | SPONSORED ADS | 0 | -25,000 | 0 | -502,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|